Indian company insights & news

    Results, dividends, orders and deals from Indian listed companies, explained in plain words. Every article is written from the company's own filing with the NSE or BSE, and links to it.

    MONARCHMonarch Networth Capital Ltd.

    Monarch Networth Capital Q2 FY27 Results: Consolidated Net Profit ₹56.56 Crore on Total Income of ₹124 Crore

    Monarch Networth Capital (NSE: MONARCH) reported consolidated total income of ₹123.52 crore and net profit of ₹56.56 crore for the quarter ended 30 Sep 2026, it said in a filing on 29 Oct 2026. Standalone total income was ₹117.40 crore and net profit ₹52.48 crore.

    • Earnings
    • stockbroking and financial services

    Blacklitt Research3 min read

    A chemical plant at night with illuminated pipes, towers and steam rising from processing units

    ACIArchean Chemical Industries Ltd.

    Archean Chemical Industries Q2 FY27 Results: Consolidated Net Profit ₹31.33 Crore on Total Income of ₹302 Crore

    Archean Chemical Industries (NSE: ACI) reported consolidated total income of ₹301.61 crore and consolidated net profit of ₹31.33 crore for the quarter ended 30 Sep 2026, it said in a filing on 29 Oct 2026. Standalone total income was ₹305.36 crore and standalone net profit ₹43.20 crore for the same quarter.

    • Earnings
    • Speciality chemicals

    Blacklitt Research3 min read

    ARCILAsset Reconstruction Company (India) Ltd.

    Asset Reconstruction Company (India) Q2 FY27 Results: Consolidated Net Profit ₹158 Crore on Total Income of ₹279 Crore

    Asset Reconstruction Company (India) (NSE: ARCIL) reported consolidated total income of ₹278.54 crore and consolidated net profit of ₹157.82 crore for the quarter ended 30 Sep 2026, it said in a filing on 29 Oct 2026. Standalone total income was ₹240.35 crore and standalone net profit ₹146.82 crore. The company's shares were listed on 17 Sep 2026 after an initial public offering.

    • Earnings
    • asset reconstruction

    Blacklitt Research2 min read

    SHAILYShaily Engineering Plastics Ltd.

    Shaily Engineering Plastics Q2 FY27 Results: Consolidated Net Profit ₹61.27 Crore on Total Income of ₹324 Crore

    Shaily Engineering Plastics (NSE: SHAILY) reported consolidated total income of ₹324.25 crore and net profit of ₹61.27 crore for the quarter ended 30 Sep 2026, and standalone total income of ₹314.63 crore and net profit of ₹66.94 crore, it said in a filing on 29 Oct 2026.

    • Earnings
    • Plastic components manufacturing

    Blacklitt Research3 min read

    A hand holding a handful of assorted capsules and tablets against a green background

    STARStrides Pharma Science Ltd.

    Strides Pharma Science Q2 FY27 Results: Consolidated Net Profit ₹134 Crore on Total Income of ₹1,434 Crore

    Strides Pharma Science (NSE: STAR) reported consolidated total income of ₹1,433.82 crore and net profit of ₹134.12 crore for the quarter ended 30 Sep 2026, it said in a filing on 29 Oct 2026. Standalone total income was ₹661.29 crore and standalone net profit ₹9.26 crore for the same quarter.

    • Earnings
    • Pharmaceuticals

    Blacklitt Research3 min read

    THYROCAREThyrocare Technologies Ltd.

    Thyrocare Technologies Q2 FY27 Results: Consolidated Net Profit ₹15.22 Crore on Total Income of ₹274 Crore

    Thyrocare Technologies (NSE: THYROCARE) reported consolidated total income of ₹274.44 crore and net profit of ₹15.22 crore for the quarter ended 30 Sep 2026, a fall from ₹47.81 crore a year earlier, it said in a filing on 29 Oct 2026. Standalone net profit for the quarter was ₹48.13 crore on total income of ₹259.19 crore.

    • Earnings
    • Diagnostics

    Blacklitt Research3 min read

    ALIVUSAlivus Life Sciences Ltd.

    Alivus Life Sciences Q2 FY27 Results: Standalone Net Profit ₹197 Crore on Total Income of ₹702 Crore

    Alivus Life Sciences (NSE: ALIVUS) reported standalone total income of ₹701.90 crore and net profit of ₹196.75 crore for the quarter ended 30 Sep 2026, it said in a filing on 29 Oct 2026. The results are presented on a standalone basis because the company's newly incorporated Brazilian subsidiary had no transactions requiring consolidation.

    • Earnings
    • Active Pharmaceutical Ingredients

    Blacklitt Research2 min read

    Add Blacklitt as preferred source